The store will not work correctly when cookies are disabled.
2-(2-Chlorophenyl)-2-((3-(piperidin-1-yl)propyl)amino)cyclohexan-1-one
ID: ALA4554571
PubChem CID: 155556448
Max Phase: Preclinical
Molecular Formula: C22H31ClN2O2
Molecular Weight: 390.96
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CCCCNC1(c2ccccc2Cl)CCCCC1=O)N1CCCCC1
Standard InChI: InChI=1S/C22H31ClN2O2/c23-19-11-3-2-10-18(19)22(14-6-4-12-20(22)26)24-15-7-5-13-21(27)25-16-8-1-9-17-25/h2-3,10-11,24H,1,4-9,12-17H2
Standard InChI Key: PVAPOLCDZSMXAA-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
11.4847 -9.8063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4835 -10.6299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1957 -11.0430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9095 -10.6294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9066 -9.8027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1939 -9.3974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1915 -8.5761 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.6144 -9.3915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3235 -9.7996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0317 -9.3918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0328 -8.5701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3196 -8.1579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6094 -8.5715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8964 -8.1607 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.6075 -10.2108 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3117 -10.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3047 -11.4467 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0130 -11.8654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0061 -12.6867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7144 -13.1054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7074 -13.9267 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4297 -12.6988 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9899 -14.3241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9811 -15.1418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6875 -15.5643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4046 -15.1589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4152 -14.3350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
8 9 1 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
5 8 1 0
13 14 2 0
8 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
20 22 2 0
21 23 1 0
21 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 390.96 | Molecular Weight (Monoisotopic): 390.2074 | AlogP: 4.45 | #Rotatable Bonds: 7 |
Polar Surface Area: 49.41 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.15 | CX LogP: 4.29 | CX LogD: 4.09 |
Aromatic Rings: 1 | Heavy Atoms: 27 | QED Weighted: 0.70 | Np Likeness Score: -0.47 |
References
1. Dimitrov IV, Harvey MG, Voss LJ, Sleigh JW, Bickerdike MJ, Denny WA.. (2019) Ketamine esters and amides as short-acting anaesthetics: Structure-activity relationships for the side-chain., 27 (7): [PMID:30792105] [10.1016/j.bmc.2019.02.010] |